In a rare example of a university tec transfer deal attracting an upfront payment, French pharma company Ipsen paying €1.25 million for a treatment licence.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.